Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| p53 signaling pathway | R-HSA-168638 | map04115 | spiramycin | 5289394 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | mephentermine | 3677 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | mephentermine | 3677 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | mephentermine | 3677 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | fenbufen | 3335 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | fenbufen | 3335 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | fenbufen | 3335 | drug-path |
| Cell cycle | R-HSA-1640170 | map04110 | fenbufen | 3335 | drug-path |
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | fenbufen | 3335 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | fenbufen | 3335 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | fenbufen | 3335 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | fenbufen | 3335 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | fenbufen | 3335 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | fenbufen | 3335 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | trimethoprim | 5578 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | trimethoprim | 5578 | drug-path |
| Adipocytokine signaling pathway | R-HSA-168638 | map04920 | trimethoprim | 5578 | drug-path |
| Shigellosis | 0 | map05131 | hydroxyzine | 3658 | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | hydroxyzine | 3658 | drug-path |
| SNARE interactions in vesicular transport | R-HSA-428625 | map04130 | hydroxyzine | 3658 | drug-path |